Literature DB >> 18602186

Extended-spectrum beta-lactamase-producing Serratia marcescens outbreak in a Bulgarian hospital.

D Ivanova1, R Markovska, N Hadjieva, I Schneider, I Mitov, A Bauernfeind.   

Abstract

We describe a nosocomial outbreak of extended-spectrum beta-lactamase (ESBL)-producing Serratia marcescens in a Bulgarian university hospital affecting nine patients on four wards. Phenotypic and genotypic (plasmid profile, randomly amplified polymorphic DNA analysis and amplified ribosomal DNA restriction analysis) analysis of the isolates indicated a single clone. The epidemic strain was resistant to oxyimino beta-lactams, aztreonam, aminoglycosides, tetracycline and chloramphenicol. It produced CTX-M-3 ESBL as demonstrated by isoelectric focusing, CTX-M PCR-RFLP and gene sequencing. The isolate was also found in the environment and from a nurse's hands, suggesting transmission by staff handling. The outbreak was controlled by patient isolation and intensified hand washing. This is the first report from Bulgaria describing a hospital outbreak caused by CTX-M-3 ESBL-producing S. marcescens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602186     DOI: 10.1016/j.jhin.2008.04.033

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  The Rcs signal transduction pathway is triggered by enterobacterial common antigen structure alterations in Serratia marcescens.

Authors:  María E Castelli; Eleonora García Véscovi
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

2.  Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss.

Authors:  Borum Suh; Il Kwon Bae; Juwon Kim; Seok Hoon Jeong; Dongeun Yong; Kyungwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

Review 3.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  Global population structure of the Serratia marcescens complex and identification of hospital-adapted lineages in the complex.

Authors:  Tomoyuki Ono; Itsuki Taniguchi; Keiji Nakamura; Debora Satie Nagano; Ruriko Nishida; Yasuhiro Gotoh; Yoshitoshi Ogura; Mitsuhiko P Sato; Atsushi Iguchi; Kazunori Murase; Dai Yoshimura; Takehiko Itoh; Ayaka Shima; Damien Dubois; Eric Oswald; Akira Shiose; Naomasa Gotoh; Tetsuya Hayashi
Journal:  Microb Genom       Date:  2022-03

5.  Risk factors for mortality in patients with Serratia marcescens bacteremia.

Authors:  Sun Bean Kim; Yong Duk Jeon; Jung Ho Kim; Jae Kyoung Kim; Hea Won Ann; Heun Choi; Min Hyung Kim; Je Eun Song; Jin Young Ahn; Su Jin Jeong; Nam Su Ku; Sang Hoon Han; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

6.  Extended Spectrum beta-Lactamases among Gram-Negative Bacterial Isolates from Clinical Specimens in Three Major Hospitals in Northern Jordan.

Authors:  Raymond G Batchoun; Samer F Swedan; Abdullah M Shurman
Journal:  Int J Microbiol       Date:  2009-09-10

7.  Recent independent emergence of multiple multidrug-resistant Serratia marcescens clones within the United Kingdom and Ireland.

Authors:  Danesh Moradigaravand; Christine J Boinett; Veronique Martin; Sharon J Peacock; Julian Parkhill
Journal:  Genome Res       Date:  2016-07-18       Impact factor: 9.043

8.  Antibiofilm and Antivirulence Properties of Indoles Against Serratia marcescens.

Authors:  Sivasamy Sethupathy; Ezhaveni Sathiyamoorthi; Yong-Guy Kim; Jin-Hyung Lee; Jintae Lee
Journal:  Front Microbiol       Date:  2020-10-30       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.